Free tool
Stocks above their 200-day average
We cover 110 companies trading above their own 200-day average. The median market value in the group is $984.54M. Across the group, the median move over the past trading day is +0.65%. 100% of the 110 with a 200-day average trade above it. Price change over the past year runs from −19.4% to +90.5% across the middle 80 percent of the group, with a median of +11.9%. Across the group, 3 companies currently carry a tier A volume signal.
Other lists in this group
Table
110 of 10,735 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| LLY.DE | Eli Lilly and Company | $1.07T | Mega cap | +73.55% |
| JNJ.DE | Johnson & Johnson | $651.71B | Mega cap | +58.93% |
| 4AB.DE | AbbVie Inc. | $471.29B | Mega cap | +32.34% |
| 6MK.DE | Merck & Co., Inc. | $379.64B | Mega cap | +91.49% |
| RHO.DE | Roche Holding AG | $370.84B | Mega cap | +41.42% |
| NOT.DE | Novartis AG | $300.14B | Mega cap | +28.89% |
| AMG.DE | Amgen Inc. | $237.76B | Mega cap | +60.12% |
| TN8.DE | Thermo Fisher Scientific Inc. | $234.00B | Mega cap | +29.67% |
| NVO.WA | Novo Nordisk A/S | $212.23B | Mega cap | −9.22% |
| NOVO-B.CO | Novo Nordisk A/S | $210.20B | Mega cap | −11.26% |
| NOV.DE | Novo Nordisk A/S | $209.27B | Mega cap | +15.22% |
| ABL.DE | Abbott Laboratories | $200.44B | Mega cap | −10.02% |
| DEMANT.CO | Demant A/S | $9.36B | Mid cap | +17.12% |
| WDH1.DE | Demant A/S | $9.33B | Mid cap | −5.53% |
| KRK.WA | Krka, d. d. | $9.20B | Mid cap | +30.59% |
| GETI-B.ST | Getinge AB (publ) | $7.01B | Mid cap | +20.89% |
| HLUN-B.CO | H. Lundbeck A/S | $6.47B | Mid cap | +8.99% |
| HLUN-A.CO | H. Lundbeck A/S | $6.40B | Mid cap | +29.71% |
| CTEC.L | Convatec Group PLC | $6.01B | Mid cap | −1.95% |
| SECT-B.ST | Sectra AB (publ) | $5.63B | Mid cap | −17.02% |
| HIK.L | Hikma Pharmaceuticals PLC | $4.61B | Mid cap | −9.62% |
| 1SXP.DE | SCHOTT Pharma AG & Co. KGaA | $4.08B | Mid cap | +1.26% |
| MCOV-B.ST | Medicover AB (publ) | $3.85B | Mid cap | −8.20% |
| CAMX.ST | Camurus AB (publ) | $3.79B | Mid cap | −15.35% |
| AFX.DE | Carl Zeiss Meditec AG | $3.19B | Mid cap | −24.83% |
| BIOA-B.ST | BioArctic AB (publ) | $3.00B | Mid cap | +12.31% |
| B72.DE | AtaiBeckley Inc. | $2.79B | Mid cap | +59.69% |
| AMBU-B.CO | Ambu A/S | $2.69B | Mid cap | −19.13% |
| BV3.DE | Bavarian Nordic A/S | $2.55B | Mid cap | +15.65% |
| BAVA.CO | Bavarian Nordic A/S | $2.51B | Mid cap | −7.97% |
| DRW3.DE | Drägerwerk AG & Co. KGaA | $2.45B | Mid cap | +70.53% |
| ONT.L | Oxford Nanopore Technologies plc | $2.41B | Mid cap | −2.24% |
| DMP.DE | Dermapharm Holding SE | $2.31B | Mid cap | +27.27% |
| EKTA-B.ST | Elekta AB (publ) | $2.20B | Mid cap | +26.10% |
| ALIF-B.ST | AddLife AB (publ) | $2.08B | Mid cap | −7.20% |
| NANO.PA | Nanobiotix S.A. | $2.05B | Mid cap | +358.21% |
| VIMIAN.ST | Vimian Group AB (publ) | $1.99B | Small cap | +12.01% |
| EMBLA.CO | Embla Medical hf. | $1.93B | Small cap | −6.94% |
| DRW8.DE | Drägerwerk AG & Co. KGaA | $1.84B | Small cap | +53.42% |
| ATT.ST | Attendo AB (publ) | $1.77B | Small cap | +80.74% |
| ALVO-SDB.ST | Alvotech | $1.74B | Small cap | −39.57% |
| CLARI.PA | Clariane SE | $1.67B | Small cap | −6.95% |
| BONEX.ST | Bonesupport Holding AB (publ) | $1.57B | Small cap | −28.26% |
| RDC.DE | Redcare Pharmacy NV | $1.49B | Small cap | −23.82% |
| AMBEA.ST | Ambea AB (publ) | $1.45B | Small cap | +38.66% |
| GDS.PA | Ramsay Générale de Santé SA | $1.42B | Small cap | +9.50% |
| CHEMM.CO | ChemoMetec A/S | $1.33B | Small cap | −3.94% |
| UPR.L | Uniphar plc | $1.33B | Small cap | +6.94% |
| SPI.L | Spire Healthcare Group plc | $1.28B | Small cap | +7.25% |
| BIOG-B.ST | BioGaia AB (publ) | $1.23B | Small cap | +13.96% |
| CVSG.L | CVS Group plc | $1.20B | Small cap | +2.05% |
| RHK.DE | RHÖN-KLINIKUM Aktiengesellschaft | $1.14B | Small cap | +24.49% |
| PHIL.MI | Philogen S.p.A. | $1.11B | Small cap | +4.75% |
| GUBRA.CO | Gubra A/S | $1.02B | Small cap | +4.79% |
| GXI.DE | Gerresheimer AG | $1.02B | Small cap | −39.73% |
| NEU.WA | NEUCA S.A. | $946.21M | Small cap | +15.02% |
| XVIVO.ST | Xvivo Perfusion AB (publ) | $929.27M | Small cap | +59.31% |
| PHN.MI | Pharmanutra S.p.A. | $921.01M | Small cap | +70.46% |
| MCAP.ST | MedCap AB (publ) | $864.73M | Small cap | −10.28% |
| SFL.MI | Safilo Group S.p.A. | $839.99M | Small cap | +20.65% |
| AMS.L | Advanced Medical Solutions Group plc | $830.96M | Small cap | +38.01% |
| GNFT.PA | Genfit S.A. | $830.56M | Small cap | +310.45% |
| APOTEA.ST | Apotea AB (publ) | $822.73M | Small cap | −26.38% |
| ARJO-B.ST | Arjo AB (publ) | $802.95M | Small cap | −15.25% |
| UU8.F | Neurogene Inc. | $795.50M | Small cap | +165.60% |
| SNT.WA | Synektik Spólka Akcyjna | $774.15M | Small cap | +53.07% |
| LBIRD.PA | Lumibird SA | $658.60M | Small cap | +57.43% |
| MEDI.OL | Medistim ASA | $512.66M | Small cap | +4.43% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | $492.64M | Small cap | +1198.08% |
| HNSA.ST | Hansa Biopharma AB (publ) | $450.66M | Small cap | +35.65% |
| AVCT.L | Avacta Group Plc | $440.62M | Small cap | +26.36% |
| CEVI.ST | CellaVision AB (publ) | $410.67M | Small cap | −5.28% |
| LNA.PA | LNA Santé SA | $405.74M | Small cap | +11.88% |
| M12.DE | M1 Kliniken AG | $401.97M | Small cap | +37.84% |
| NIOX.L | NIOX Group Plc | $392.35M | Small cap | −9.49% |
| EGTX.ST | Egetis Therapeutics AB (publ) | $390.51M | Small cap | +51.35% |
| CRNA.OL | Circio Holding ASA | $384.19M | Small cap | +1733.85% |
| VOX.WA | Voxel S.A. | $376.42M | Small cap | −18.11% |
| OPT.L | Optima Health plc | $355.51M | Small cap | +9.32% |
| HUM.ST | Humana AB (publ) | $350.23M | Small cap | +81.84% |
| SBS.DE | Stratec SE | $322.43M | Small cap | −16.91% |
| ANCR.L | Animalcare Group PLC | $314.33M | Small cap | +28.86% |
| MED.DE | MEDICLIN Aktiengesellschaft | $301.82M | Small cap | +75.81% |
| SUS.ST | Surgical Science Sweden AB (publ) | $279.10M | Small cap | −48.69% |
| TSTL.L | Tristel plc | $276.02M | Small cap | +19.76% |
| TRMED.OL | Thor Medical ASA | $268.94M | Small cap | +135.13% |
| ALMDT.PA | Median Technologies SA | $256.00M | Small cap | +90.42% |
| IPH.PA | Innate Pharma S.A. | $240.15M | Small cap | +1.19% |
| CLN.WA | Celon Pharma S.A. | $235.59M | Small cap | −3.06% |
| STIL.ST | Stille AB | $216.03M | Small cap | −4.26% |
| AOTI.L | AOTI, Inc. | $205.47M | Small cap | +159.09% |
| ICE.WA | Medinice S.A. | $204.25M | Small cap | +595.19% |
| LIK.DE | LIMES Schlosskliniken AG | $199.75M | Small cap | +70.66% |
| CARA.ST | Carasent AB (publ) | $178.28M | Small cap | −10.62% |
| VME.DE | Viromed Medical AG | $164.76M | Small cap | +85.71% |
| NYKD.OL | Nykode Therapeutics AS | $160.76M | Small cap | +204.86% |
| ENE.WA | Centrum Medyczne ENEL-MED S.A. | $154.41M | Small cap | +16.28% |
| MRC.WA | Mercator Medical S.A. | $148.80M | Small cap | +35.88% |
| BICO.ST | BICO Group AB (publ) | $147.45M | Small cap | −17.00% |
| GENO.ST | Genovis AB (publ.) | $146.60M | Small cap | −16.91% |
| V5P.F | Vytrus Biotech, S.A. | $146.35M | Small cap | +225.93% |
| PAX.ST | Paxman AB (publ) | $139.52M | Small cap | −21.45% |
| SEDANA.ST | Sedana Medical AB (publ) | $132.45M | Small cap | −22.05% |
| MVIR.ST | Medivir AB (publ) | $131.70M | Small cap | +4.73% |
| XI3.F | Bioceltix S.A. | $131.58M | Small cap | −28.67% |
| BVXP.L | Bioventix PLC | $124.26M | Small cap | −30.64% |
| CRAD-B.ST | C-Rad AB (publ) | $122.23M | Small cap | +6.49% |
| SCP.WA | Scope Fluidics S.A. | $120.06M | Small cap | −9.90% |
| SYNACT.ST | SynAct Pharma AB | $111.82M | Small cap | +10.82% |
| ALECR.PA | Eurofins-Cerep SA | $107.03M | Small cap | −3.80% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.